Overview Exploratory Trial of TAS-303 in Female Patients With Stress Urinary Incontinence Status: Completed Trial end date: 2018-04-30 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the efficacy and safety of TAS-303 in female patients with stress urinary incontinence. Phase: Phase 2 Details Lead Sponsor: Taiho Pharmaceutical Co., Ltd.